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Adenosine kinase (AK) is only found in eukaryotes. Recently, a Mycobacterium tuberculosis (MTub)
protein exhibiting greater sequence similarity to ribokinases (RK) was identiﬁed as AK. We have
expressed AKs from MTub, human and Chinese hamster (CH) cells in Escherichia coli and also AK
from human and MTub in AK-deﬁcient CH cells. While both E. coli and CH cells expressing mamma-
lian AKs efﬁciently metabolized various adenosine analogs, those expressing MTub-AK were com-
pletely inactive. The AK activity of the MTub protein was very low (50-fold lower than E. coli RK)
and it was not stimulated by phosphate or inhibited by several AK inhibitors. These results raise
questions over MTub protein’s true function and whether it functions as AK in cells.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Adenosine kinase (AK) catalyzes the phosphorylation of adeno-
sine (Ado) to adenosine monophosphate (AMP) using the c-phos-
phate of the co-substrate Mg/ATP2. AK belongs to the
phosphofructokinase B type (PfkB) family of sugar kinases, which
includes many proteins such as ribokinase (RK), inosine-guanosine
kinase, fructokinase, and 1-phosphofructokinase [1–3]. Recent
studies on AK have focused on designing inhibitors, particularly
of the human and parasitic protozoan forms. In humans, it has
been proposed that inhibitors of AK could produce various phar-
macological effects by increasing intravascular Ado concentrations
and act as anti-inﬂammatory agents [3,4]. In parasitic protozoa
(e.g. plasmodium, toxoplasma, leishmania and trypanosoma),
which lack the ability to synthesize purine nucleotides de novo,
it has been suggested that AK inhibitors could attenuate their
growth by blocking the purine salvage pathway [5,6].
Until recently, the AK activity and genes were only known to be
present in eukaryotic organisms [3]. However, Long et al. [7] have
recently reported identiﬁcation of an enzyme from Mycobacterium
tuberculosis (Accession no. P83374) that corresponds to the only
known bacterial AK. The identiﬁcation of AK activity in M. tubercu-
losis is of much interest because AK can permit the intracellular
conversion of nucleoside analogs to toxic anti-metabolites andchemical Societies. Published by Ethus could prove useful in treating multidrug-resistant tuberculo-
sis. The identiﬁcation of a protein that carried out AK function inM.
tuberculosis (referred to here as MTub-AK) was of much importance
to us due to our long-standing interest in AK and related enzymes
[3]. We have previously carried out extensive studies on the effects
of adenosine analogs on mammalian cells, and many different
kinds of mutants affected in AK were isolated and characterized
[8]. We were also among the ﬁrst to clone and characterize the
AK cDNA as well as its gene structure from mammalian species
[2,9,10]. Our biochemical studies on AK have led to the discovery
of phosphate or pentavalent ion dependency, a property shared
by eukaryotic AKs and also other enzymes of the PfkB family
[3,11,12]. In the present work, we have further characterized
MTub-AK and compared its properties with mammalian AKs, both
in vitro and in a cellular setting. The results of our studies show
that MTub-AK behaves very differently from mammalian AKs in
various respects and it is unable to metabolize various adenosine
analogs in cellular systems. These results raise important concerns
regarding the functioning of this protein as AK in cells.2. Materials and methods
2.1. Reagents
D-[1-3H] ribose (20 Ci/mmol), D-[1-3H] arabinose (20 Ci/mmol),
D-[14C] fructose (300 mCi/mmol), D-[1-3H] xylose (15 Ci/mmol),
and D-[2,8-3H] adenosine (40 Ci/mmol) were purchased fromlsevier B.V. All rights reserved.
2232 J. Park et al. / FEBS Letters 583 (2009) 2231–2236American Radiolabeled Chemicals (St. Louis, MO). Adenosine ana-
logs were from Sigma–Aldrich Co.
2.2. Expression of human, Chinese hamster and MTub-AK in E. coli cells
The full length sequence of MTub-AK (Rv2202c, Accession no.
P83734) was PCR ampliﬁed fromM. tuberculosis DNA using speciﬁc
oligonucleotide primers. The AK cDNA for human (Accession no.
NM_006721.2) and Chinese hamster (P55262) have been described
in earlier work [2,9,13]. These sequences were subcloned into
pET15b, and E. coli BL21 cells were transformed with these plas-
mids. To examine the effect of adenosine analogs, E. coli cells con-
taining these plasmids were grown overnight at 37 C in LB
medium. Cells transformed with the same plasmid containing no
insert were used as control. Next day, the overnight cultures were
diluted 1:500 with fresh media in presence of 0.1 mM IPTG to in-
duce the AKs. After 1 h, different concentrations of the adenosine
analogs were added. After 4 h, the growth of cells in each culture
was determined by measuring their optical density at 600 nm.
Assuming the cell growth observed in the absence of any drug as
100%, relative growth in presence of adenosine analogs was deter-
mined. For puriﬁcation of MTub-AK, E. coli BL21 cells containing
this gene were induced with 0.1 mM IPTG for 6 h at room temper-
ature. The (His)6-tagged protein was puriﬁed to >90% purity by
nickel afﬁnity and gel-ﬁltration chromatography and stored at
20 C in 10% glycerol.
2.3. Studies with CHO cells expressing human or MTub-AK
Toyr-4 is a toyocamycin-resistant mutant of CHO cells, which
lacks AK (<0.5% of wild-type) due to a large deletion in the AK gene
[14]. We have transfected Toyr-4 cells with the mammalian
expression plasmid pcDNA3.1, harboring either human AK cDNA
or MTub-AK DNA. Stable transfectants expressing these genes were
obtained by growing the cells in presence of G-418 (650 lg/ml) for
more than 1 month. The relative plating efﬁciency of cells express-Fig. 1. A consensus neighbor-joining tree for the PfkB family of proteins based on 100
proteins. The tree was constructed as described in earlier work [10] and the numbers
regarding tree construction methods are provided as Supplementary data information
guanosine kinase.ing either the human or MTub-AK in presence of various adenosine
analogs was determined as described in earlier work [9,15].2.4. Enzyme activity assays
AK activity was measured using [3H]-adenosine as described
previously [11,15]. All assays were carried out at 37 C in 20 mM
Tris–maleate buffer (pH 7.0) containing 10 mM KCl and 10 mM
MgCl2. The concentrations of Ado and ATP, when held ﬁxed, were
10 lM and 5 mM, respectively. Assays for human and E. coli RK
were carried out as previously described [16]. The catalytic efﬁ-
ciency of each enzyme for different substrates was expressed as
a function of kcat and Km (kcat/Km in min1 mM1). The kcat was cal-
culated by dividing Vmax by the molar concentration of the enzyme
in each reaction, as described previously [11].3. Results
3.1. Sequence similarity and phylogenetic analysis of MTub-AK
As mentioned previously, AK belongs to the PfkB family of car-
bohydrate kinases, which are identiﬁed by the presence of two
highly conserved sequence motifs in the N- and C-terminal regions
[1,3]. Despite the presence of these conserved signatures, proteins
of the PfkB family exhibit low overall sequence identity (20%),
which often prevents determination of substrate speciﬁcity of a
newmember. The function of MTub-AK also could not be identiﬁed
based on its amino acid sequence [7]. In fact, pair-wise sequence
identity shows that MTub-AK is more closely related to ribokinases
and fructokinases than AK from various sources [3,7]. This infer-
ence is also clearly evident from the phylogenetic tree shown in
Fig. 1. In this tree, MTub-AK branched as a distantly related mem-
ber of the RK and fructokinase clade, whereas AKs from different
sources formed a distinct clade.bootstrap samples showing the relationship between MTub-AK and other related
on the nodes are bootstrap scores. The accession numbers and other information
. The abbreviations for the enzymes are: SCRK, fructokinase and INGK, inosine-
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Fig. 3. Effects of adenosine analogs on the viability of wild-type CHO cells (–}–),
Toyr-4 cells (––), and Toyr-4 cells transfected with either MTub (–h–) or human
(–j–) AK. The plating efﬁciency of the parental Toyr-4 cells in the absence of any
adenosine analog was regarded as 100%.
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ability of E. coli cells to metabolize adenosine analogs
Since Long et al. [7] have reported that this MTub protein func-
tions as AK despite exhibiting greater sequence similarity to the
RKs and fructokinases, we have tested whether this enzyme can
phosphorylate various nucleoside analogs in a cellular setting. To
study this, E. coli BL21 cells were transformed with pET15b vectors
harboring MTub-AK, CHO-AK, or human AK. E. coli cells trans-
formed with an empty vector served as a control. Upon addition
of IPTG, all of these cells expressed comparable levels of the recom-
binant proteins as determined by SDS–polyacrylamide gel-electro-
phoresis (results not shown). We have tested the effects of various
adenosine analogs on the growth of these cells. Since most adeno-
sine analogs are prodrugs that need to be phosphorylated by AK
before they can exert their cytotoxic effects, only the cells express-
ing active intracellular AK are expected to show sensitivity to such
analogs. The results of these experiments for some of the adeno-
sine analogs tested are presented in Fig. 2.
As seen, the growth of normal E. coli cells, or cells transformed
with an empty control vector, was not affected in presence of dif-
ferent concentrations of various adenosine analogs. These results
support that E. coli cells do not contain AK and also indicate that
other enzymes in E. coli are not able to metabolize these analogs
to their toxic forms. In contrast to these cells, the growth of
E. coli cells transformed with either the human or CHO-AK was
inhibited in a dose-dependent manner by very low concentrations
of different adenosine analogs (viz. toyocamycin, tubercidin, 8-aza-
adenosine and 6-methylmercaptopurine riboside (6-MeMPR))
(Fig. 2). These results provide evidence that AK from human and
Chinese hamster sources is functioning in E. coli as expected to
convert (phosphorylate) these analogs to their toxic forms. How-
ever, in contrast to these results, cells transformed with the
MTub-AK behaved similarly to the control cells, and their growth
was not affected in presence of these Ado analogs. These results
showed that MTub-AK is not able to metabolize different adeno-
sine analogs that are efﬁciently metabolized by other well-charac-
terized AKs. Long et al. [7] have reported that MTub-AK is0
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Fig. 2. Effects of adenosine analogs on the viability of E. coli cells transformed with plas
alone (––). The growth of E. coli cells transformed with the empty vector in the absenresponsible for the sensitivity of MTub to 2-methyladenosine.
Hence, we also examined the effect of various concentrations
(0.1–200 lg/ml) of both 2-methyladenosine as well as 1-methyl-
adenosine on the growth of E. coli cells. Surprisingly, both these
analogs exhibited no cytotoxicity to various cells expressing differ-
ent AKs (data not shown). The lack of toxicity of 1-methyladeno-
sine and 2-methyladenosine to cells expressing different AKs
indicates that these analogs are either very poor substrates of AK
or that their metabolism does not produce toxic effects in E. coli
cells.0
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mids containing MTub (–h–), CHO (–j–), or human (–}–) AK, or with the vehicle
ce of any drug was regarded as 100%.
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Fig. 4. Effects of two non-nucleoside AK inhibitors (A) compound 3998-0118 and
(B) compound 8008-6198 [15] on the activity of puriﬁed MTub (–h–) and human
(–j–) AK.
Table 1
Substrate speciﬁcity of M. tuberculosis AK and other related enzymes.
Enzyme Substrate
speciﬁcity (kcat/
Km) min1 mM1
Relative AK activity
of various enzymesa
Substrate speciﬁcity
(kcat/Km) for adenosine/
ribose
Ribose Adenosine
MTub AK 1.1 9.9 1 9.9
Human AK 3.9 3200 320 820
Human RK 1100 7.8 0.79 0.007
E. coli RK 12000 530 53 0.044
a Assuming the activity of M. tuberculosis AK as 1, relative AK activity of other
enzymes was determined.
2234 J. Park et al. / FEBS Letters 583 (2009) 2231–22363.3. Effect of expression of MTub-AK in AK- mutants of CHO cells
In view of the above results, we have also examined the effect of
expression of MTub protein in an AK-deﬁcient mammalian system.
These studies were carried out with a CHO cell mutant (Toyr-4)
that is lacking AK [8,14]. We have stably transfected this mutant
with the AK cDNA/gene from human (also CHO) or M. tuberculosis.
The sensitivity of the resulting cell lines to various adenosine ana-
logs was determined by means of plating efﬁciency experiments.
The results of these experiments for two of the adenosine analogs
tubercidin and formycin A are presented in Fig. 3. In comparison to
the parental cells, the Toyr-4 mutant is >100-fold resistant to these
compounds (Fig. 3) [14]. The Toyr-4 cells stably transfected with
the human AK cDNA (or CHO-AK cDNA, results not shown), be-
came as sensitive to these analogs as the wild-type CHO cells, indi-
cating restoration of AK activity (Fig. 3). In sharp contrast to these
results, Toyr-4 cells transfected with MTub-AK showed no change
in their sensitivity to these adenosine analogs and displayed simi-
lar levels of resistance as the control Toyr-4 cells (Fig. 3). Results
very similar to those shown were obtained with a number of other
analogs (viz. toyocamycin, 8-azaadenosine and 6-MeMPR) that
were tested (results not shown). Further, as seen in our studies
with E. coli cells, 1-methyladenosine and 2-methyladenosine did
not exhibit any toxicity towards any of these cell lines up to the
highest concentration tested (i.e. 200 lg/ml) (results not shown).
3.4. Biochemical studies on human and M. tuberculosis AK
In view of the differences between the activity of mammalian
and MTub-AK in cellular settings, we have also examined biochem-
ical properties of the puriﬁed MTub enzyme. One key characteris-
tics of various eukaryotic AKs is their requirement for inorganic
phosphate (Pi) for catalytic activity [3,11]. AKs from various
sources such as human and Chinese hamster, spinach, yeast and
protozoan, are all greatly stimulated by Pi [3,11,15]. In contrast,
addition of up to 20 mM Pi had no effect on the activity of MTub-
AK [7] (results not shown). In our recent work, we have identiﬁed
several potent inhibitors of human AK, which inhibit AK in a com-
petitive manner with respect to adenosine [15]. We have tested the
effects of these inhibitors on MTub-AK (Fig. 4). Compounds 3998-
0118 and 8008-6198, which inhibited human AK in a low
micromolar range, produced no signiﬁcant inhibition of the MTub
enzyme up to 1 mM. The other AK inhibitors tested (viz. BTB00475,
BTB00480, and BTB00523), whose results are not shown, also gave
similar results.
In view of the above differences in the behavior of MTub-AK, we
have also measured the catalytic efﬁciency of MTub-AK for several
simple sugars. As seen in Table 1, the MTub-AK showed a 9-fold
preference for Ado over ribose. The activity for fructose was similar
to ribose, and other sugars tested (viz. arabinose, xylose, and gal-
actose) showed negligible activity as substrates for this enzyme
(results not shown). However, the difference in the behavior of
MTub-AK became clearer, when its substrate speciﬁcity was com-
pared with some of the other related enzymes such as human AK,
human RK, and E. coli RK. As shown in Table 1, human AK shows a
820-fold preference for Ado over ribose, whereas human RK and
E. coli RK favor ribose over Ado by a factor of 141 and 23, respec-
tively. In comparison to these enzymes, the mere 9-fold preference
for Ado over ribose seen with MTub-AK indicates that this enzyme
is not very stringent in terms of its substrate selection. More
importantly, the overall catalytic efﬁciency of MTub-AK is greatly
lower than those of human AK, human RK, and E. coli RK. Human
AK, for example, is approximately 320-fold more efﬁcient in phos-
phorylating Ado than MTub-AK (Table 1). It is of particular signif-
icance that the catalytic efﬁciency of human RK and E. coli RK for
Ado, despite the fact that they showed a preference for ribose overAdo, was higher (E. coli RK) or at least comparable (human RK) to
that observed for MTub-AK (Table 1). These results indicate that
although MTub-AK can phosphorylate Ado in vitro, this activity
is very low and it is even less than that observed for E. coli RK
for Ado.
4. Discussion
Members of the PfkB family of proteins, which exhibit AK activ-
ity, have only been found in the eukaryotic organisms in the past.
Hence, the report of a PfkB family protein in MTub that exhibited
AK activity was of much interest, and it necessitated closer exam-
ination of its characteristics. This MTub protein exhibited much
higher sequence similarity to RKs and fructokinases than to AK
from various sources. Further, the functional form of this MTub
protein is a dimer [7] similar to RKs from various sources [16,17],
whereas all known AKs are monomers [18,19]. Another aspect in
which MTub-AK resembles RK more than other AKs is its ionic
requirement. Like other RKs, the catalytic activity of MTub-AK is
stimulated in the presence of monovalent metal ions such as K+
[20], while AKs from various sources generally do not require
J. Park et al. / FEBS Letters 583 (2009) 2231–2236 2235monovalent ions for their activity [3]. On the other hand, the bio-
logical activity of various AK shows a strong dependence upon
the presence of pentavalent ions [3,11], which had no effect on
the MTub protein.
The results of various experiments presented here further illus-
trate that the MTub enzyme in question behaves very differently
from other well-characterized AKs. Most importantly, this protein,
when expressed either in bacterial or mammalian cells, failed to
metabolize various Ado analogs to their toxic forms, while the
AKs from human or CHO cells were very active in this regard. These
results raise serious concerns whether this MTub protein indeed
functions as AK in a cellular setting. In this context, it should be
noted that although our results conﬁrm that this MTub protein
exhibits AK activity in vitro, we ﬁnd this activity to be very low
(about 320-fold lower) in comparison to human AK. This result dis-
agrees with an earlier report by Long and Parker [21], who reported
comparable speciﬁc activity of both human AK and the MTub en-
zymes for Ado. We believe that the catalytic activity of human
AK in this earlier study was greatly underestimated in comparison
to the MTub protein due to a number of reasons. The AK activity
from various sources shows a marked dependence upon the pres-
ence of inorganic phosphate [11], which was not added to the en-
zyme reactions, whereas K+ required for the activation of the M.
tuberculosis protein was [21]. Also, the assays for human AK were
carried out at pH 6, while those for theM. tuberculosis protein were
at pH 8. TheM. tuberculosis protein functions optimally at pH 8 [7],
whereas the human enzyme at pH 6 only shows half to a third of its
maximal activity (pH 7.5–8.5) [22].
Another factor to consider in determining whether this MTub
protein functions as AK in cells is the relative abundance of Ado
and other simple sugars in cellular environment. Ado exists in
micromolar amounts in cells [3], whereas sugars such as ribose
and fructose are in millimolar ranges, as reﬂected in the Km values
of the enzymesmetabolizing cellular Ado and sugars [3]. Therefore,
although the MTub protein in question shows 9-fold higher cata-
lytic efﬁciency for Ado over ribose in vitro, which is unusual and
it could be due to convergent evolution [7], it is more likely in-
volved in the metabolism of ribose or some other sugar than Ado
in a cellular environment where the sugar exists in great excess
over Ado. In this context, the inferences from the recently reported
crystal structure of the MTub protein [23] should also be inter-
preted carefully. Although this structure was solved with a bound
Ado molecule in the active site, it is clear that ribose can also bind
to the same site. Most of the residues (four out of ﬁve) that form
polar contacts with the ribose moiety of Ado in MTub-AK (Asp12,
Gly48, Asn52, and Asp257) are conserved in E. coli RK (Asp16,
Gly42, Asn46, and Asp255) [18,19], indicating that the same inter-
action will occur with ribose. Thus E. coli RK should also be able to
bind Ado, since it shows 50-fold higher AK activity than MTub-
AK. In contrast, the structure around the purine base of Ado in
MTub-AK shows no similarity in the residue conservation and
arrangement to other known structures of AK [18,19].
As noted earlier, the PfkB family of carbohydrate kinases can
phosphorylate the hydroxymethyl group of a wide variety of sugar
moieties [1,3]. Recent searches of the Swiss-Prot database with the
two conserved sequence motifs found in these proteins (Accession
nos. PS00583 and PS00584) identiﬁed 213 proteins belonging to
this family [3]. These proteins included various known members
of the PfkB family of proteins (e.g. RKs, AKs, fructokinase, 1-phos-
phofructokinase, etc.), but also a number of uncharacterized sugar
kinases from bacterial sources. Because the sequence identity
among these divergent PfkB members is very low (20%), the sub-
strate speciﬁcity of a new member often cannot be readily pre-
dicted. Such was the case for this M. tuberculosis protein, which
exhibited greater sequence similarity to RK than to AK, but exhib-
ited very little RK catalytic activity [7]. Although in view of its pref-erence for adenosine over ribose, this protein was suggested to
function as AK [7], the results presented here indicate that it seems
less likely that this protein carries out adenosine phosphorylation
in vivo. It is possible that this protein is involved in the phosphor-
ylation of some other substrate, whose identity remains to be
determined.
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